EGFR and cancer: The four cancer‐associated pathways that were found (false discovery rate (FDR) ≤ 0.05) are DNA damage response, ErbB (epidermal growth factor receptor family) signaling pathway, endometrial cancer, and chromosomal and microsatellite instability in colorectal cancer (Table S5, Supporting Information).